Last update:

Ophthalmology news

Low dose atropine eye drops safe and effective for short-sightedness in children, clinical trial suggests

Low-concentration atropine eye drops are a safe and effective treatment for short-sightedness (myopia) in UK children, although the effects are small, suggests a clinical trial published by The BMJ.

Researchers identify which eye infections pose greatest threat to vision

Eye surgery today is safer than ever, yet ophthalmologists must remain watchful for a rare but serious complication that can threaten sight within days: a bacterial eye infection called endophthalmitis. Now, clinician-scientists ...

Lab-grown aging eye model reveals early AMD markers in weeks

The rods and cones in your eyes are responsible for helping you see, but what is responsible for helping them? Retinal pigment epithelium cells are their caretakers, but environmental, genetic and aging factors can strain ...

New genetic map of the human eye reveals clues to vision loss

An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works. The breakthrough could help explain why millions of ...

Eye drop formulation can treat dry eye disease

Researchers at Baylor College of Medicine and Okayama University in Japan have developed and tested in mice a promising new eye drop formulation for treating dry eye disease. The team reports in Investigative Ophthalmology ...

Project expands access to care for children with amblyopia

A group of pediatric eye disease researchers has launched an open-access tool designed to help manage pediatric cases of amblyopia, a condition in which the brain fails to properly develop normal vision in one or both eyes ...

Low-dose eye drops can manage adult myopia for 24 hours

Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults. Professor ...

Seeing keratoconus earlier with light polarization and AI

Keratoconus is a progressive eye disease that weakens and thins the cornea, the clear front surface of the eye. In its early, subclinical stage, the cornea can still appear normal on routine exams. Yet this is when accurate ...

VR headsets may actually reduce risk of dry eye

Virtual reality (VR) gaming has gained significant attention in recent years, with an increasing number of users integrating VR and immersive headsets into their daily lives. These devices provide highly immersive visuals, ...

Protecting against diabetic corneal disease

A Cedars-Sinai study helps explain why half of diabetes patients experience deterioration of the cornea, the transparent dome-shaped outer layer of the eye that provides protection and focuses incoming light. The findings, ...

Combating intractable blindness with 3D bio-printed retina

Retinal vein occlusion (RVO) is one of the leading causes of vision loss worldwide, often triggered by chronic diseases such as hypertension and diabetes. Similar to a blocked water pipe causing backflow and pressure buildup, ...

Who is more likely to lose vision due to high brain pressure?

If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this disorder can develop without noticeable symptoms, making it hard to catch. A new study looks at ...